MedElevator Войти в исследования
← Поиск публикаций

DOI 10.33393/dti.2023.2574

Медицинская библиотека · Drug target insights · 2023

Treatment with levosimendan in an experimental model of early ventilator-induced diaphragmatic dysfunction.

Zambelli Vanessa, Murphy Emma J, Delvecchio Paolo, Rizzi Laura, Fumagalli Roberto, Rezoagli Emanuele, Bellani Giacomo

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Mechanical ventilation (MV) is a life-saving approach in critically ill patients. However, it may affect the diaphragmatic structure and function, beyond the lungs. Levosimendan is a calcium sensitizer widely used in clinics to improve cardiac contractility in acute heart failure patients. In vitro studies have demonstrated that levosimendan increased force-generating capacity of the diaphragm in chronic obstructive pulmonary disease patients. Thus the aim of this study was to evaluate the effects of levosimendan administration in an animal model of ventilator-induced diaphragmatic dysfunction (VIDD) on muscle contraction and diaphragm muscle cell viability.

METHODS

Sprague-Dawley rats underwent prolonged MV (5 hours). VIDD+Levo group received a starting bolus of levosimendan immediately after intratracheal intubation and then an intravenous infusion of levosimendan throughout the study. Diaphragms were collected for ex vivo contractility measurement (with electric stimulation), histological analysis and Western blot analysis. Healthy rats were used as the control.

RESULTS

Levosimendan treatment maintained an adequate mean arterial pressure during the entire experimental protocol, preserved levels of autophagy-related proteins (LC3BI and LC3BII) and the muscular cell diameter demonstrated by histological analysis. Levosimendan did not affect the diaphragmatic contraction or the levels of proteins involved in the protein degradation (atrogin).

CONCLUSIONS

Our data suggest that levosimendan preserves muscular cell structure (cross-sectional area) and muscle autophagy after 5 hours of MV in a rat model of VIDD. However, levosimendan did not improve diaphragm contractile efficiency.

Для цитирования: Zambelli Vanessa, Murphy Emma J, Delvecchio Paolo, Rizzi Laura, Fumagalli Roberto, Rezoagli Emanuele, Bellani Giacomo. Treatment with levosimendan in an experimental model of early ventilator-induced diaphragmatic dysfunction.. Drug target insights. 2023. DOI: 10.33393/dti.2023.2574.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.